A Cochrane review included 25 studies with a total of 429 participants. Treatment consisted of laparoscopic ovarian "drilling" (LOD) in order to induce ovulation in subfertile women with PCOS. There was no evidence of a difference in live birth rate (9 trials, 1210 women) when compared with clomiphene citrate + tamoxifen (OR 0.81, 95% CI 0.42 to 1.53; 1 trial, n=150), gonadotrophins (OR 0.97, 95% CI 0.59 to 1.59; 2 trials, n=318), aromatase inhibitors (OR 0.84, 95% CI 0.54 to 1.31; 2 trials, n=407) or clomiphene citrate (OR 1.21, 95%CI 0.64 to 2.32; 1 trial, n=176). There was evidence of significantly fewer live births following LOD compared with clomiphene citrate + metformin (OR 0.44; 95% CI 0.24 to 0.82; I² 78%, 2 trials, n=159). Multiple pregnancy rates were lower with ovarian drilling than with gonadotrophins (1% versus 16%; OR 0.13, 95% CI 0.03 to 0.52; 5 trials, n=166). There was no evidence of a difference in miscarriage rates between the two groups.
Comment: The quality of evidence is downgraded by inconsistency (variability in results across studies).